Andere talen Bionime Corporation

Aandelen

4737

TW0004737002

slotkoers Taiwan S.E. Andere beurzen 00:00:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
68 ^TWD	-0,44%		-1,16%	-9,09%

15/03	Bionime Corporation rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
14/03	Bionime Corporation kondigt dividend aan voor het jaar dat eindigt op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Bionime Corporation Announces Dividend for the Year Ended December 31, 2023	14/03
Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
Bionime Corporation Announces TFDA Approval for iFree Continuous Glucose Monitoring System Second-Class Medical Device License	13-10-23
Bionime Corporation Announces Resignation of Marvin Wu as Globle Sales Division Officer	18-08-23
Bionime Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10-08-23
Bionime Corporation Announces Appointment of Aling Lai as New Member to the Remuneration Committee	09-08-23
Bionime Corporation Appoints Aling Lai as Additional Member of Audit Committee	30-06-23
Bionime Corporation Approves Cash Dividends, Payable on August 18, 2023	30-06-23
Bionime Corporation Announces Election of Aling Lai as an Additional Independent Director	30-06-23
Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	11-05-23
Bionime Corporation Revises Cash Dividend for 2022	10-05-23
Bionime Corporation Appoints Chen Hui-Zhen as Corporate Governance Officer	10-05-23
Bionime Corporation Announces Cash Dividend for 2022	14-03-23
Bionime Corporation Announces Resignation of Tai,Tsung-Kai as Institutional Director, Effective April 30, 2023	03-03-23
Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10-11-22
Bionime Corporation Approves the Factory Area to Expand Building the Clean Room to Accommodate Production Equipment and Increase Production Capacity	09-11-22
Bionime Announces the Introduction of Its Revolutionary iFree CGM for Diabetes Management Coming Soon	02-11-22
Bionime Corporation to Launch the Rightest iFree CGM, Proposed to Offer Precise and Accurate Blood Glucose Measurement and Monitoring	01-11-22
Bionime RIGHTEST iFree CGM System - An Innovative Approach to Keep Track of Every One Health	25-10-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bionime Corporation

Aandelen

4737

TW0004737002

Andere talen

Filters